Skip to content
Search AI Powered

Latest Stories

PM announces UK general election: Pharmacy bodies urge political parties to address sector challenges

PM announces UK general election: Pharmacy bodies urge political parties to address sector challenges

CPE encourages pharmacy owners to contact their local Prospective Parliamentary Candidates seeking their support for community pharmacy

As Prime Minister Rishi Sunak announces the forthcoming UK general election, pharmacy bodies are calling on all political parties to commit to solving the issues facing the sector.


The next UK general election will be held on 4 July, Sunak announced it on Wednesday afternoon during a press conference outside 10 Downing Street.

“As the election is called it’s imperative that any incoming government addresses the crisis in primary care and the looming cliff edge facing pharmacies, which for millions of people are the front door to the NHS and a crucial source of frontline health care,” said Paul Rees, Chief Executive of the National Pharmacy Association (NPA).

Noting that the first responsibility of the government is to keep its people safe and healthy, he emphasised the importance of addressing the “deep funding gap that is pushing record numbers of pharmacies to the edge of closure and beyond, exacerbating the issues of waiting lists for GPs and hospital care.”

“You can be sure that we will be pressing all parties hard to commit to solving issues like pharmacy closures and medicine shortages which are affecting millions in communities across the country who just want access to local health support,” Paul added.

Janet Morrison, CEO of Community Pharmacy England (CPE), stated that they had been preparing for the news of a UK General Election for many months, briefing and building support for community pharmacy across all political parties.

She noted that this work remained urgent and critical, as community pharmacies are in “deep distress.”

She added that they will continue to raise this issue and caution about the risks of failing to support pharmacies across the political spectrum.

Additionally, she underscored the importance of recognising the value that community pharmacy can provide if it has the “right investment and support.”

“The election period will be an important time for building supporters in readiness for the new Parliament,” Janet said, adding that they would be discussing with LPCs about how they could collaborate on this during their National Meeting today.

“To support our national engagement, we will be encouraging all LPCs and pharmacy owners to contact their local Prospective Parliamentary Candidates seeking their support for community pharmacy – resources and guidance to help with this are already available,” she added.

Janet also mentioned that they would discuss the impact of the ongoing 2024/25 pharmacy funding negotiations with the Department of Health and Social Care.

“The prospect of more delays is deeply concerning for pharmacy owners who urgently need good news: accelerating this negotiation, whether in the coming weeks or with the new Government, remains our focus,” she said.

 

 

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
David Webb
David Webb, NHS England's Chief Pharmaceutical Officer
David Webb, NHS England's Chief Pharmaceutical Officer

Sigma Conference: "Community pharmacy ready to make a profound contribution to 10 Year Health Plan," says David Webb

A national community pharmacy prescribing service remains a long-term goal of the government, according to NHS chief pharmaceutical officer, David Webb.

The Labour Party in its election manifesto last year said it would “create a Community Pharmacist Prescribing Service, granting more pharmacists independent prescribing rights”.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less